US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 1.970
  • -0.180-8.37%
Close Jul 19 16:00 ET
241.05MMarket Cap-1758P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mersana Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

9.24M

+18.50%
EPS(YoY)

-0.16

+69.23%
Analyst Rating

Buy

Jun 30, 2024

Mersana Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.147M--
--2024/Q2-- / 9.134M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--
Nov 7, 20232023/Q37.698M / 9.344M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.147M--
--2024/Q2-- / 9.134M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--
Nov 7, 20232023/Q37.698M / 9.344M--

Unlock Free Earnings Estimates

Mersana Therapeutics Earnings Reports

  • Mersana Therapeutics | 10-Q: Quarterly report

    May 9 09:02 ET

  • Mersana Therapeutics | 10-K: Annual report

    Feb 28 08:52 ET

  • Mersana Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 08:42 ET

  • Mersana Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 08:53 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg